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Abstract
Background: The use of live microorganisms to influence positively the course of intestinal
disorders such as infectious diarrhea or chronic inflammatory conditions has recently gained
increasing interest as a therapeutic alternative. In vitro and in vivo investigations have demonstrated
that probiotic-host eukaryotic cell interactions evoke a large number of responses potentially
responsible for the effects of probiotics. The aim of this study was to improve our understanding
of the E. coli Nissle 1917-host interaction by analyzing the gene expression pattern initiated by this
probiotic in human intestinal epithelial cells.
Methods: Gene expression profiles of Caco-2 cells treated with E. coli Nissle 1917 were analyzed
with microarrays. A second human intestinal cell line and also pieces of small intestine from BALB/
c mice were used to confirm regulatory data of selected genes by real-time RT-PCR and cytometric
bead array (CBA) to detect secretion of corresponding proteins.
Results:  Whole genome expression analysis revealed 126 genes specifically regulated after
treatment of confluent Caco-2 cells with E. coli Nissle 1917. Among others, expression of genes
encoding the proinflammatory molecules monocyte chemoattractant protein-1 ligand 2 (MCP-1),
macrophage inflammatory protein-2 alpha (MIP-2α) and macrophage inflammatory protein-2 beta
(MIP-2β) was increased up to 10 fold. Caco-2 cells cocultured with E. coli Nissle 1917 also secreted
high amounts of MCP-1 protein. Elevated levels of MCP-1 and MIP-2α mRNA could be confirmed
with Lovo cells. MCP-1 gene expression was also up-regulated in mouse intestinal tissue.
Conclusion:  Thus, probiotic E. coli Nissle 1917 specifically upregulates expression of
proinflammatory genes and proteins in human and mouse intestinal epithelial cells.
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Background
Probiotic microorganisms have traditionally been charac-
terized as viable nutritional agents conferring benefits to
the health of the human host [1]. The definition of the
term "probiotic" has evolved through the years. The latest
and most appropriate definition describes probiotics as
"live microorganisms which when administered in ade-
quate amounts confer a health benefit on the host" [2].
Beneficial activities of probiotics most likely result from
complex interactions of the microorganisms with the
intestinal microflora and the gut epithelium of the indi-
vidual [3]. A proposed mechanism by which probiotics
mediate their effects is the modulation of the innate
immune response both to antiinflammatory [4] and
proinflammatory directions. Furthermore, probiotic bac-
teria have been shown to enhance the adaptive immune
response and antibody formation [7,8]. Inhibition of
adherence of attaching and effacing organisms [9], modu-
lation of the mucosal barrier function [10,11] as well as
inhibition of neutrophil migration [12] may also be
important mechanisms whereby probiotics can impact in
intestinal diseases.
Next to lactic acid bacteria and the probiotic yeast S. boul-
ardii, the non-pathogenic E. coli strain Nissle 1917 (EcN)
of serotype O6:K5:H1 is one of the best characterized pro-
biotics. EcN was originally isolated by the army surgeon
Dr. Alfred Nissle in 1917 from the feces of a soldier who
did not develop diarrhea during a severe outbreak of shig-
ellosis [13]. A controlled clinical trial published recently
implies probiotic EcN being as effective as standard med-
ication with a dose of 1,5 g/day mesalazine in remission
maintenance of ulcerative colitis. In this study recurrance
rates were 33.9% for mesalazine treatment compared to
36.4% for treatment with EcN (Mutaflor®) [14]. Recently,
we have demonstrated, that recombinant EcN had no
effect on migration, clonal expansion and activation sta-
tus of specific CD4+ T cells, neither in healthy mice nor in
animals with acute colitis [15]. Despite the successful
therapeutic applications of EcN, only limited information
is available about the beneficial traits contributing to the
strains' probiotic character. Several strain specific charac-
teristics have been detected so far including expression of
two microcins [16], presence of six iron-uptake systems or
lack of defined virulence factors [17]. Moreover, EcN
exhibits a unique semirough lipopolysaccharide pheno-
type, responsible for its serum sensitivity [18,19]. All these
properties might be advantageous for EcN in competing
with other colonic bacteria or adapting to the intestinal
situation. However, the mechanisms underlying the pro-
biotic nature, especially at the molecular level, yet have to
be elucidated.
In this study we aimed to analyze the genomic expression
program initiated by the interaction of probiotic EcN with
human intestinal epithelial cells. Our results demonstrate
a transient proinflammatory signaling of human and
mouse intestinal epithelial cells illustrated by induced
gene expression of MCP-1, MIP-2α and MIP-2β after treat-
ment with EcN.
Methods
Cell culture conditions
The human colon adenocarcinoma cell lines Caco-2 [20]
and Lovo [21] were maintained in IMDM cell culture
medium (Invitrogen, Karlsruhe, Germany) containing
10% fetal calf serum (PAA Laboratories, Cölbe, Germany)
and 250 µg/ml penicillin/streptomycin (Invitrogen) at
37°C in a cell culture incubator. Caco-2 cells were used
from passage 12 – 26. Cells were split twice a week at a
ratio of 1:3. 4 – 8 × 105 cells per well were seeded in six
well plates (Nunc, Wiesbaden, Germany) and cultured for
approximately four days until confluence.
Animals
BALB/c mice were obtained from Harlan (Borchen, Ger-
many). The animal experiments reported here were per-
mitted from the district authority of Braunschweig and
were conducted according to the German animal protec-
tion law.
Preparation of bacteria
E. coli strain Nissle 1917 was isolated from a tablet of
Mutaflor® (Ardeypharm, Herdecke, Germany) cultured on
MacConkey plates (Oxoid, Wesel, Germany). The isolate
was serotyped and confirmed by EcN specific PCR [22]. E.
coli K12 laboratory strain MG1655 was kindly provided
by Ulrich Dobrindt (Institute for Molecular Infection
Biology, Würzburg, Germany). Both strains were grown
overnight in Luria Bertani (LB) medium (Invitrogen) at
37°C on a shaker. The cultures were then diluted 1:100 in
50 ml prewarmed IMDM medium containing 10% fetal
calf serum and grown at 37°C. Bacteria were harvested in
late logarithmic phase, after reaching an OD600 = 1.
Coculture of cell lines
Confluent Caco-2 and Lovo cells (0.4 – 1 × 107 cells per
well) were washed with phosphate buffered saline (PBS)
and cocultured with a low bacterial MOI (multiplicity of
infection) of 1 (1.3 – 3.3 × 106  CFU/ml) in IMDM
medium containing 10% fetal calf serum at 37°C in a cell
culture incubator for 6 hours. For time-dependent expres-
sion experiments conditioned media was collected by cen-
trifugation after coincubation for 6 hours, redissolved in 3
ml IMDM medium with 10% fetal calf serum containing
200 µg/ml gentamicin (Sigma-Aldrich, Taufkirchen, Ger-
many) and 250 µg/ml penicillin/streptomycin (Invitro-
gen), and used to incubate the Caco-2 cells for another 42
hours. Prior to RNA isolation cells were washed twice with
PBS.BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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Tissue coculture
Experimental setup was performed following a modified
protocol described by Cima et al. [23]. In brief, small
intestine was dissected, washed and opened logitudinally,
cut into 5 mm long pieces and washed with PBS/DTT for
15 min shaking at 37°C to remove the excess mucus. Tis-
sue pieces were then washed with PBS followed by two
washing steps with HBSS/2% fetal calf serum. 3 – 5 tissue
pieces per well were placed in a 24 well plate in IMDM
containing 10% fetal calf serum without antibiotics. Bac-
teria were applied at 5 × 105 CFU/ml.
Cocultivation of Caco-2 cells with inactivated bacterial 
pellets or bacteria conditioned media
Bacteria were grown overnight as described above. Over-
night culture was diluted in IMDM with 10% fetal calf
serum. For coincubation experiments with conditioned
media (CM), bacterial suspensions were again incubated
for 5 hours to an OD600 = 1 at 37°C on a shaker and
diluted to 1 × 108 CFU/ml in IMDM medium containing
10% fetal calf serum. CM was centrifuged and superna-
tants were sterile filtered. Caco-2 cells were incubated with
inactivated bacteria or CM for 6 hours. For experiments
with inactivated bacteria, an aliquot of the bacterial sus-
pension was taken at an OD600 = 0.5 and centrifuged. The
bacterial pellet was fixed in 4% paraformaldehyde for one
hour at room temperature, washed four times with PBS,
redissolved in IMDM medium with 10% fetal calf serum
and adjusted to an MOI of 2. Aliquots of the fixed bacteria
were plated onto Müller-Hinton-agar to test for sterility.
RT-PCR
RNA from cells and tissue was extracted using TriFast FL
(PEQLAB, Erlangen, Germany) according to the manufac-
turer's protocol, following DNAse I digestion with DNA-
free® (Ambion, Huntingdon Cambridgeshire, UK). Sam-
ples were pooled prior to reverse transcription with 200 U
Superscript II® (Invitrogen) for 45 minutes at 42°C in 20
µl assays containing 1 µl Oligo dT-primers and 10 mM
deoxynucleoside triphosphates (dNTPs). Conventional
PCR was performed with AmpliTaq Gold® DNA polymer-
ase (Applied Biosystems, Darmstadt, Germany) in 20 µl
assays containing 0.25 pmol primers and 0.5 mM dNTP
using the following cycling conditions: Activation of Taq
polymerase for 10 minutes at 95°C, followed by a first
round of 10 cycles each consisting of a 30 second denatur-
ing interval at 95°C, a 90 second annealing step at the
respective primer Tm and a primer extension at 72°C for
again 90 seconds. This first amplification step was fol-
lowed by a second round of 27 cycles, consisting of 15 sec-
onds denaturation, 45 seconds annealing and 90 seconds
extension. PCR products were separated in 2% agarose
gels and visualized by ethidium-bromide staining. All
primers used in this study are listed in table 1.
Table 1: Primers used for real-time RT-PCR.
Product 5' Sequence 3' Sense/antisense Product length, bp Tm, °C
DUSP5 AGC CCC AAG AGC AAC TGT GAT T Sense 163 54.3
AGT CCC GAG AAC CTA CCC TGA G Antisense
ELF3 GTC AGC AAG CCA GCC CCT ACC AC Sense 202 62.1
GGA TCC CCC TTC TTG CAG TCA CGA Antisense
EMP3 GCG AGA ATG GCT GGC TGA AG Sense 204 58.3
GGA TCT CCT CGG CGT GAA TG Antisense
MCP-1 GTC TCT GCC GCC CTT CTG TG Sense 94 55.9
AGG TGA CTG GGG CAT TGA TTG Antisense
MIP-2α TTT TAG GTC AAA CCC AAG TTA GTT Sense 150 49.0
TTC TTG GAT TCC TCA GCC TCT ATC Antisense
MIP-2β AAG AAG CTT ATC AGC GTA TCA T Sense 150 50.6
AAT AAG TAG AAC CCT CGT AAG AAA Antisense
NFκBIA CGC CCA AGC ACC CGG ATA CAG C Sense 193 58.7
TTC AGC CCC TTT GCA CTC ATA ACG Antisense
RPS-9 CGC AGG CGC AGA CGG TGG AAG C Sense 92 61.1
CGA AGG GTC TCC GCG GGG TCA CAT Antisense
TNFαIP3 ATT GGC CTC TTT GAT ACA CTT TTG Sense 201 52.9
CTC ATC CCT GCT CCT TCC CTA TCT Antisense
VEGF AAG GAG GAG GGC AGA ATC ATC ACG Sense 192 58.8
CAC ACT CCA GGC CCT CGT CAT TG Antisense
DUSP5 indicates dual specificity phosphatase 5; ELF3, E74-like factor 3 (ets domain transcription factor, epithelial-specific); EMP3, epithelial 
membrane protein 3; NFκBIA, nuclear factor of kappa light polypeptide gene enhancer in B cell inhibitor, alpha; MCP-1, chemoattractant protein-1 
ligand 2; MIP-2α, macrophage inflammatory protein-2 alpha; MIP-2β, macrophage inflammatory protein-2 beta; RPS-9, ribosomal protein S9; 
TNFαIP3, tumor necrosis factor, alpha-induced protein 3; VEGF, vascular growth factor and Tm, melting temperature.BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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DNA microarray hybridization
Quality and integrity of the total RNA isolated from 1 ×
106 cells was controlled by running all samples on an Agi-
lent 2100 Bioanalyzer (Agilent Technologies, Waldbronn,
Germany). For biotinylated target synthesis, RNA was
labeled using standard protocols supplied by the manu-
facturer (Affymetrix, Santa Clara, CA). Briefly, 5 µg total
RNA was converted to dsDNA using 100 pmol of a
T7T23V primer (Eurogentec, Seraing, Belgium) contain-
ing a T7 promoter. The cDNA was then used directly in an
in vitro transcription reaction in the presence of bioti-
nylated nucleotides. The concentration of biotin-labeled
cRNA was determined by UV absorbance. In all cases, 12.5
µg of each biotinylated cRNA preparation were frag-
mented and placed in a hybridization cocktail containing
four biotinylated hybridization controls (BioB, BioC,
BioD, and Cre) as recommended by the manufacturer.
Samples were hybridized to an identical lot of Affymetrix
HG_U133A arrays for 16 hours. After hybridization, the
GeneChips were washed, stained with strepavidin-phyco-
erythrin and read using an Affymetrix GeneChip fluidic
station and scanner.
Data analysis
Analysis of microarray data was performed using Affyme-
trix Microarray Suite 5.0, Affymetrix MicroDB 3.0 and the
Affymetrix Data Mining Tool 3.0. For normalization all
array experiments were scaled to a target intensity of 150,
otherwise using the default values of the Microarray Suite.
Results were filtered as follows: Genes are considered
strongly regulated when their fold change is greater than
or equal 2 or less than or equal -2, the statistical parameter
for a significant change is less than 0.01 (change p-value
for changes called increased) or greater than 0.99 (change
p-value for changes called decreased). Additionally, the
signal difference of a certain gene should be greater than
100. Genes are considered as weakly regulated when their
fold change is greater than or equal 1.5 or less than or
equal -1.5, the statistical parameter for a significant
change is less than 0.001 or greater than 0.999 and the sig-
nal difference of a certain gene should be greater than 40.
Real-time RT-PCR
Total RNA preparation and cDNA synthesis were per-
formed as described for RT-PCR. Quantitative real-time
RT-PCR was done with an ABI PRISM cycler (Applied Bio-
systems, Foster City, CA) using SYBR Green PCR kit from
Stratagene and specific primers optimized to amplify 90 –
250 bp fragments from the genes under investigation
(Tab. 1). A threshold was set in the linear part of the
amplification curve, and the number of cycles needed to
reach it was calculated for every gene. Relative mRNA lev-
els were determined by using included standard curves for
each individual gene and further normalization to the
housekeeping gene RPS9. Melting curves established the
purity of the amplified band.
Cytokine analysis by CBA
Quantification of cytokines was performed using the BD®
Cytometric Bead Array Human Chemokine Kit I with anti-
bodies specific for IL-8, RANTES, MIG, MCP-1 and IP-10
(BD Biosciences, Heidelberg, Germany). Supernatants of
3–5 tissue culture wells were pooled and data were
acquired as described previously [24] by flow cytometry
with a FACSCalibur® flow cytometer (BD Biosciences)
using 2-color detection. Data analysis was performed by
BD Bioscience Cytometric Bead Array software.
Field emission scanning electron microscopy
Caco-2 cells were seeded on 22 mm Biocoat Collagen I
coated coverslips (BD Biosciences) in six well plates and
grown until confluence as described above. After coincu-
bation, cells were washed three times with 1 × PBS and
fixed with a fixation solution containing 5% formalde-
hyde and 2% glutaraldehyde in cacodylate buffer (0.1 M
cacodylate, 0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose,
pH 6.9), washed with cacodylate buffer and then with TE-
buffer (10 mM TRIS, 2 mM EDTA, pH 6.9). Finally, cells
were scratched from the wells, pelleted and embedded in
2% aqueous agar before dehydrating with a graded series
of acetone (10, 30, 50, 70, 90, 100%) on ice for 30 min at
each step. Samples in 100% acetone were allowed to reach
room temperature before another change of 100% ace-
tone. They were then subjected to critical-point drying
with liquid CO2 (CPD 030, BAL-TEC, Schalksmühle, Ger-
many). The dried cells were covered with a gold film of
about 10 nm by sputter coating (SCD040, BAL-TEC)
before examination in a field emission scanning electron
microscope Zeiss DSM 982 Gemini (Carl Zeiss, Oberko-
chen, Germany) using the Everhart Thornley SE detector
and the inlens detector in a 50:50 ratio at an acceleration
voltage of 5 kV. Data were stored digitally on MO-disks.
Results
Genome-wide expression analysis of Caco-2 cells treated 
with E. coli Nissle 1917
Among the 22,000 genes and expressed sequence tags
present on Affymetrix HG_U133A arrays, we identified
138 sequences differentially expressed upon treatment of
confluent Caco-2 cells with EcN. Due to some genes being
repeatedly present on the array, we finally found a total of
126 individual genes to be regulated. They belonged to a
wide variety of gene classes (Fig. 1). From the coding
sequences that could be assigned to one of these classes,
17% pertained to signaling pathways. The remainder of
the genes encoded for molecules involved in protein fold-
ing and biosynthesis (10%), transcription and translation
(10%), transport (8%), metabolism (6%) as well as
energy pathways (5%), immune response (4%) prolifera-BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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tion (3%), differentiation (1%) and apoptosis (1%). A
better part of them, like genes coding for hypothetical pro-
teins and unannotated ORFs, could not be allocated to
one of the classes and was therefore assigned as others
(35%). Selected genes of each class, that showed at least a
two fold regulation in one of the two experiments, were
summarized in table 2. 9 of these genes were selected for
further investigations. They were choosen on the basis of
both, prominent changes in their gene expression profiles
and their putative biological implication at the outset of
our study. Significantly elevated mRNA levels were found
for dual-specificity phosphatase 5 (DUSP5), chemoat-
tractant protein-1 ligand 2 (MCP-1), macrophage inflam-
matory protein-2 alpha (MIP-2α), macrophage
inflammatory protein-2 beta (MIP-2β), tumor necrosis
factor alpha induced protein 3 (TNFαIP3) and ets domain
transcription factor ELF3. Vascular endothelial growth fac-
tor (VEGF), active in angiogenesis, vasculogenesis and
endothelial cell growth, was up-regulated as well. Yet
another gene, up-regulated by EcN treatment, was human
nuclear factor of kappa light chain gene enhancer in B
cells inhibitor alpha (NFκBIA), which inhibits the action
of NF-κB [25]. Downregulation of gene expression was
observed for epithelial membrane protein 3 (EMP3). The
mRNA expression levels of these genes were validated by
real-time RT-PCR. The entire data set of our microarray
experiments is accessible as MIAME format online with
accession number GSE2232 [48].
Real-time RT-PCR to confirm data obtained with gene 
expression analysis arrays
Electron micrographs of the coculture experiments are
shown in figure 2A. Panel A I illustrates untreated Caco-2
cells. Cells coincubated with E. coli MG1655, serving as
control strain, and EcN are depicted in panels A II and A
III, respectively. Array data for MCP-1, MIP-2α, MIP-2β,
DUSP5, ELF3 and NFκBIA were verified by real-time RT-
PCR (Fig. 2B). The strongest up-regulation of mRNA
expression, compared to control cells, could be detected
for MCP-1. There was a 103 fold increase, compared to an
mRNA level elevated only 8 fold after treatment with E.
coli MG1655. Additionally, gene expression levels of MIP-
2α, MIP-2β and DUSP5 were more than 20 fold higher
than the controls, when Caco-2 cells were treated with
EcN. Array data obtained for TNFαIP3 and VEGF could
also be confirmed by real-time RT-PCR, but the increase in
mRNA levels was almost identical for Caco-2 cells treated
with E. coli MG1655 or EcN. Therefore, up-regulation of
TNFαIP3 and VEGF could not be considered to be an EcN
specific effect. We were not able to verify down-regulation
of EMP3 by real-time RT-PCR as indicated by our array
data (data not shown). In summary, the regulation pat-
tern of EcN-treated Caco-2 cells compared to treatment
with E. coli MG1655 after 6 hours coculture suggested a
specific EcN-mediated up-regulation of MCP-1, MIP-2α,
MIP-2β, DUSP5, NFκBIA and ELF3 expression in human
intestinal epithelial cells.
Classification of genes regulated in confluent Caco-2 cells by coculture with EcN for 6 hours Figure 1
Classification of genes regulated in confluent Caco-2 cells by coculture with EcN for 6 hours. Analysis of microar-
ray data from two independent experiments resulted in 126 genes being regulated. These genes could be assigned to different 
classes according to their involvement in biological processes (percent by number of genes per class).
Immune
response (4%)
Differentiation  (1%)
Energy
pathways
(5%)
Protein folding and
biosynthesis (10%)
Others (35%) Signaling (17%)
Transcription and
translation (10%)
Proliferation (3%) Transport (8%)
Metabolism (6%) Apoptosis (1%)BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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Table 2: Differential gene expression of Caco-2 cells cocultured with EcN.
Fold changea
Functional 
category
Gene symbol GB Acc. No.b Chip 1 Chip 2 Description and/or putative function
Immune response MCP-1 (CCL2) S69738.1 11.1 3.1 Enhances the inflammatory response, upregulated by IL1α and 
TNFα
CD9 NM_001769.1 1.7 3.6 Involved in platelet activation and aggregation; expressed in 
hematopoetic and epithelial cells
MIP-2α (CXCL2) M57731.1 4.4 8.1 Produced by activated monocytes, expressed at inflammation 
sites, up-regulated by IL1α and TNFα
MIP-2β (CXCL3) NM_002090.1 6.5 10.4 Plays a role in inflammation, autocrine effect on endothelial cells
NK4 NM_004221.1 -1.7 -2.5 May play a role in lymphocyte acitivation, angiogenesis inhibitor, 
putative therapeutic agent for gastric cancer
Signaling AGT NM_000029.1 1.7 2.6 Serine protease inhibitor
CNIH NM_005776.1 2.6 6.9 EGF-signaling in oocyte
DUSP5 U16996.1 13.1 3.4 Hydrolase, negative feedback role in IL-2 signaling, deactivation 
of mitogen- or stress-activated protein kinases
ID2 NM_002166.1 2.8 4.2 Essential for constitution of the intestinal mucosal barrier, is 
downregulated by TGFβ
IFNGR2 NM_005534.1 1.8 2.4 Protein translocator
NFκBIA AI078167 6.3 3.3 Downregulation of NF-κB activity, contributed in Crohn's 
disease
NFκBIE NM_004556.1 3.3 2.1 Inhibits NF-κB
PRDX4 NM_006406.1 1.7 3.6 Regulates the activation of NF-κB by modulation of IκBα 
phosphorylation
DDIT (RTP801) NM_019058.1 20.9 4.0 HIF-1α responsive proapoptotic protein
TNFαIP3 NM_006290.1 4.3 3.3 Interacts with NAF1 and inhibits TNF-induced NF-κB 
dependent gene expression
SFN X57348 -1.6 -2.2 Exonuclease specific for small oligoribonucleotides, sensitive 
epithelial marker
Transcription and 
translation
ELF3 U73844.1 3.3 1.8 Epithelial specific ets transcription factor, regulates MIP3α 
expression which is NF-κB dependent
ILF3 BC003086.1 -4.3 -2.0 May faciliate ds RNA-regulated gene expression
TIEG NM_005655.1 2.5 44.7 Krüppel-like transcription factor, up-regulated by TGFβ
XBP1 NM_005080.1 2.5 2.7 May act as transcription factor in B-cells
Apoptosis BNIP3 U15174.1 3.0 2.7 Apoptosis inducing protein, binding to BCL2
Differentiation NDRG1 NM_006096.1 2.4 6.8 Growth inhibitory role, induced app. 20 × during in vitro 
differentiation of Caco-2
Proliferation EMP3 NM_001425.1 -2.2 -4.4 Probably involved in cell proliferation
VEGF H95344 2.1 2.2 Induced by mek1, role of vascular endothelial growth factor in 
IBD
a Fold change is the factor of mRNA regulation from EcN-treated cells and non-treated cells according to the signal values itself and to the change 
value from Affymetrix analysis software. Minus fold change values indicate genes with decreased transcription. Results have been performed by two 
independent hybridization experiments (Chip 1, Chip 2).
b GB Acc. No. indicates GenBank accession number.
Detection of MCP-1 in Caco-2 coculture supernatants by 
CBA analysis
Supernatants from Caco-2 cells cocultured with EcN and
E. coli MG1655 were analyzed for several cytokines. Com-
pared to untreated Caco-2 cells and cells treated with E.
coli MG1655, coculture with EcN significantly increased
release of MCP-1 protein (Fig. 3), indicating an EcN spe-
cific up-regulation of this proinflammatory molecule.
Additionally, EcN treatment of Caco-2 cells resulted in an
increased secretion of IP-10 (interferon gamma-inducible
cytokine IP-10; data not shown).
EcN specific up-regulation of MCP-1 and MIP-2α is not a 
Caco-2 cell specific phenomenon
To exclude that the EcN specific up-regulation of proin-
flammatory molecules MCP-1 and MIP-2α was a feature
specific for Caco-2 cells, coculture experiments were per-
formed with the human colon adenocarcinoma cell lineBMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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Electron microscopy of coculture experiments and real-time RT-PCR analysis Figure 2
Electron microscopy of coculture experiments and real-time RT-PCR analysis. (A) Electron microscopy of conflu-
ent Caco-2 cells (I) cocultured with E. coli MG1655 (II) or EcN (III) was performed in order to visualize the interaction between 
cells and bacteria. (B) Validation of mRNA expression levels of Caco-2 cells by quantitative real-time RT-PCR. After 6 hours of 
coincubation with either E. coli MG1655 (+ K12) or EcN (+ EcN), total RNA was isolated, reversely transcribed, and relative 
mRNA expression levels for selected genes and the housekeeping gene RPS-9 (as internal control) were analyzed in duplicate 
real-time RT-PCR assays. Relative mRNA amounts were normalized with respect to expression levels of untreated Caco-2 
cells (fold change = 1). The figure is representative of two independent experiments. MCP-1 indicates chemoattractant pro-
tein-1 ligand 2; MIP-2α, macrophage inflammatory protein-2 alpha; MIP-2β, macrophage inflammatory protein-2 beta; DUSP5, 
dual specificity phosphatase 5; NFκBIA, nuclear factor of kappa light polypeptide gene enhancer in B cell inhibitor, alpha; 
TNFαIP3, tumor necrosis factor, alpha-induced protein 3; VEGF, vascular growth factor and ELF3, E74-like factor 3 (ets 
domain transcription factor, epithelial-specific).
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Lovo. Therefore, confluent Lovo cells were cocultured
with EcN or E. coli MG1655 for 6 hours, respectively. As
already documented for Caco-2 cells, EcN again provoked
a strong specific up-regulation of these two proinflamma-
tory molecules. The gene expression level of MCP-1 was
89 fold higher compared to control cells, whereas treat-
ment with E. coli MG1655 resulted in a 9 fold increase
(Fig. 4). In addition, MIP-2α was 15 fold up-regulated
after treatment with EcN in comparison to a 2 fold eleva-
tion mediated by E. coli MG1655. Results obtained from
conventional RT-PCR also revealed an EcN specific induc-
tion of MIP-2β (data not shown). Consequently, up-regu-
lation of MCP-1 and MIP-2α after treatment with EcN was
not a feature of one cell line but rather a general EcN spe-
cific effect on human intestinal epithelial cells.
Gene expression of MCP-1, MIP-2α and MIP-2β is time-
dependent
Subsequently, we measured time kinetics of gene expres-
sion of selected proinflammatory molecules. Extended
treatment of Caco-2 cells with EcN or E. coli MG1655 for
another 24 or 48 hours revealed that EcN-mediated gene
expression of MCP-1, DUSP5 and NFκBIA peaked after 6
hours and returned to base levels after 24 hours (Fig. 5).
In contrast, expression of MIP-2α and MIP-2β increased
further and reached maximum values after 24 hours.
However, longer incubation with EcN resulted again in a
decreased MIP-2α and MIP-2β gene expression. E. coli
MG1655 influenced the expression of most of the selected
genes just slightly at any time, but revealed a peak for MIP-
2β expression after 24 hours, similar to EcN (Fig. 5), sug-
gesting that the observed time course of regulation of this
proinflammatory cytokine was not EcN specific.
EcN induced expression of MIP-2α and MIP-2β is not 
dependent on viable bacteria
We also aimed to elucidate whether the observed EcN spe-
cific expression of selected genes was merely a result of
contact between bacterial surfaces and Caco-2 cells and
additionally, whether the secretion of active bacterial
metabolites was required for the EcN specific induction of
the selected genes. Hence, Caco-2 cells were either cocul-
tured with inactivated bacteria or conditioned media
(CM) as described in Materials and Methods. Our results
Gene expression of MCP-1 and MIP-2α in Lovo cells Figure 4
Gene expression of MCP-1 and MIP-2α in Lovo cells. 
Validation of mRNA expression levels of Lovo cells after 6 
hours coculture with E. coli MG1655 (+ K12) or EcN (+ 
EcN). Relative mRNA expression levels for MCP-1, MIP-2α 
and RPS-9 (as internal control) were analyzed in duplicate 
real-time RT-PCR assays. Relative mRNA amounts were nor-
malized with respect to expression levels of untreated Lovo 
cells (fold change = 1). The figure is representative of three 
independent experiments. MCP-1 indicates chemoattractant 
protein-1 ligand 2; MIP-2α, macrophage inflammatory pro-
tein-2 alpha.
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MCP-1 secretion of Caco-2 cells after treatment with EcN Figure 3
MCP-1 secretion of Caco-2 cells after treatment with 
EcN. Caco-2 cells were cocultured with E. coli MG1655 (+ 
K12) and EcN (+ EcN) for 6 hours. Culture supernatants 
were analyzed for several cytokines using the cytometric 
bead array kit I from BD Bioscience. Cytokine quantity is 
depicted as pg/ml. Data are presented as mean from two 
independent experiments.
Caco-2
+ K12
+ EcN
concentration [pg/ml]
78
60
332
0 100 200 300 400
MCP-1BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
Page 9 of 13
(page number not for citation purposes)
indicated that culturing of Caco-2 cells with bacteria CM
did not lead to an EcN specific regulation of the selected
genes in Caco-2 cells (Tab. 3). Thus, EcN apparently did
not secrete active metabolites responsible for specific gene
expression. Additionally, for the induction of MCP-1 and
NFκBIA gene expression (Fig. 2B) live bacteria were neces-
sary, as no EcN specific gene expression could be meas-
ured after exposure of Caco-2 cells to inactivated bacteria
(Tab. 3). In contrast, mRNA levels achieved by incubation
with formalin killed EcN for MIP-2α, MIP-2β, EMP3,
DUSP5 and ELF3 were equivalent to live bacteria. Incuba-
tion over 24 h (data not shown) led to a decrease of EcN
specific gene expression correlating with the data pre-
sented in figure 5. These results suggested that the effect of
EcN on the gene expression profile of Caco-2 cells was not
only dependent on one single pathway but a combined
action of viable bacteria and membrane bound or secreted
factors.
MCP-1 is up-regulated in small intestine after EcN 
treatment
Our results indicate that the EcN mediated expression of
proinflammatory molecules was a short- time effect (Fig.
5). After investigation of the influence of EcN on human
cell lines, we next examined the effect of EcN on mouse
intestinal epithelial layer. Cima et al. described an effi-
cient method for the differential isolation of intestinal
epithelial cells along the villus-crypt axis of the small
intestine [23]. Using a modification of this method, pieces
of small intestine were cocultured with EcN or E. coli
MG1655 for 6 hours to analyze the impact of EcN on
mouse primary tissue culture. Several reasons prompted
us to use small intestinal tissue for these experiments.
Since contact between bacteria and intestinal epithelial
cells was a required condition for the impact of EcN, a
smooth removal of the mucus layer was necessary. This is
ensured for small intestine as it has a thinner mucus layer
than the colon [26]. Additionally, the murine small intes-
tine is nearly bacteria-free in contrast to a high bacterial
density in the colon [26]. Thus, the use of small intestine
for primary tissue culture enabled a specific bacteria-cell
interaction in contrast to the colon. In order to maintain
an intact cell organization and to prevent any stress that
might influence the cellular gene expression profile, small
tissue pieces were used. Real-time RT PCR revealed a 23
fold increase of MCP-1 expression after treatment with
EcN compared to non-treated tissue (Fig. 6). In contrast to
EcN, coculture with E. coli MG1655 yielded an elevated
mRNA level of only 4 fold confirming our results
obtained from experiments with confluent human cell
lines. Summarized, our data obtained from primary
mouse tissue culture confirmed the data of cell culture
experiments with two human intestinal epithelial cell
lines and corroborated the finding that EcN was able to
specifically provoke a proinflammatory host response.
Discussion
Our results demonstrate that EcN up-regulates gene
expression of molecules involved in pro- as well as antiin-
flammatory processes. A proinflammatory response of
intestinal epithelial cells to EcN was mainly demonstrated
by the temporary up-regulation of MCP-1 gene expression
in confluent human cell lines and in primary mouse tissue
culture as well as by an increased secretion of this chem-
okine. This EcN specific change of MCP-1 gene expression
could neither be induced with bacteria conditioned media
nor with formalin inactivated organisms suggesting that
for EcN mediated MCP-1 gene expression viable bacteria
Time-dependency of the gene expression profile of Caco-2 cells treated with EcN Figure 5
Time-dependency of the gene expression profile of Caco-2 cells treated with EcN. Caco-2 cells were cocultured 
with EcN and E. coli MG1655 for 6, 24 and 48 hours. Gene expression at indicated time points was measured by real-time RT-
PCR.
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are necessary. MCP-1 is produced by many cells, including
epithelial, endothelial and mast cells as well as tumor
cells, and shows chemotactic activity for monocytes,
basophils, natural killer cells and T lymphocytes during
inflammation. Among other things, MCP-1 influences the
release of specific enzymes of these target cells [27-30].
MCP-1 is expressed under many pathological conditions,
including asthma and inflammatory bowel diseases
[31,32]. Infection of human macrophages, which have a
central role in innate immune response to bacteria, with
non-pathogenic Lactobacillus rhamnosus GG, results in an
enhanced MCP-1 expression and an induction of T helper
cell type 1 (Th1) cell migration [33]. Earlier this year, Lan
et al. have shown that exposure of primary murine colonic
epithelial cells to the same Lactobacillus strain also resulted
in an exclusive induction of MCP-1 and MIP-2α expres-
sion [34]. Moreover, it has been reported, that lactobacilli
are able to activate myeloid dendritic cells that skew CD4+
and CD8+ T cells to Th1 and Tc1 polarization [35]. Earlier
studies have shown that MCP-1 expression also shifts the
immune response towards release of Th2 cytokines [36]
and thus can potentially affect antibacterial defenses.
Although it seems unexpected at first sight that the probi-
otic EcN up-regulates MCP-1 mRNA expression and pro-
tein secretion, an important role of this proinflammatory
molecule might be established in protecting the host from
bacterial infection through induction of a strong T cell
immune response, thus providing a reasonable explana-
tion for the EcN induced expression of this chemokine.
The neutrophil attracting chemokines MIP-2α and MIP-
2β represent two additional genes involved in inflamma-
tory processes and are exhibiting a number of immu-
noregulatory activities. Both of which showed an
increased expression in our coculture experiments after 6
hours, reaching peak levels after 24 hours. Subcutaneous
injection of MIP-2 into footpads of C3H/HeJ mice elicited
an inflammatory response characterized by neutrophil
infiltration, suggesting MIP-2 to be an endogenous medi-
ator playing a role in the host response during inflamma-
tory processes [37]. The MIP-2 expression of
lipopolysaccharide (LPS) or IL-1β stimulated intestinal
epithelial cells is amplified by butyrate, a metabolite of
nonpathogenic, resident bacteria. This is a potential
mechanism by which resident bacteria may regulate
inflammatory processes in the small intestine [38]. In
contrast to MCP-1, EcN mediated expression of MIP-2α
and MIP-2β seemed to be independent on the viability of
the probiotic in our experiments, as inactivated bacteria
induced gene expression as well. Thus, it appears that EcN
can induce a potent proinflammatory cytokine response
which is in part dependent on the viability of the bacteria.
It can be speculated that the local induction of proinflam-
matory immune responses within the intestinal immune
system characterized by up-regulation of MCP-1, MIP-2α
and MIP-2β upon contact with probiotic EcN might
reflect being part of the host defense process against path-
ogenic bacteria through the establishment of a protective
immunological barrier. However, further in vitro and espe-
MCP-1 gene expression in small intestine Figure 6
MCP-1 gene expression in small intestine. After 
smooth removal of the mucus layer, 3–5 tissue pieces from 
small intestine were cocultured with E. coli MG1655 (+ K12) 
or EcN (+ EcN) for 6 hours. Relative mRNA amounts were 
normalized with respect to expression levels of tissue pieces 
cultured in IMDM + 10% fetal calf serum without antibiotics 
(fold change = 1). The figure is representative of three inde-
pendent experiments.
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Table 3: EcN specific expression of selected genes in Caco-2 cells cocultured with inactivated bacteria or bacteria conditioned media 
for 6 hours.
Gene Inactivated EcN EcN CM
DUSP5 (+) no EcN specific gene regulation
ELF3 (+) no EcN specific gene regulation
MCP-1 no EcN specific gene regulation no EcN specific gene regulation
MIP-2α (+++) no EcN specific gene regulation
MIP-2β (++) no EcN specific gene regulation
NFκBIA no EcN specific gene regulation no EcN specific gene regulation
Gene expression was analyzed by real-time RT-PCR and differences of fold changes for EcN and E. coli MG1655 were compared. EcN specific fold 
change of Caco-2 cell gene expression (+) between 0.5 and 2, (++) between 2 and 10 and (+++) > 10.BMC Medical Genetics 2005, 6:43 http://www.biomedcentral.com/1471-2350/6/43
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cially in vivo experiments are needed to provide evidence
that such mechanisms are part of the repertoire of protec-
tive responses exhibited by EcN in the intestine.
The transcription factor NF-κB and the corresponding
pathway play an important role in proinflammatory sign-
aling [39,40]. Prevention of the NF-κB translocation into
the nucleus by the IκB proteins NFκBIA and NFκBIB leads
to inhibition of NF-κB, followed by suppression of proin-
flammatory genes. In our experiments up-regulated gene
expression of the transcription inhibitor NFκBIA could be
observed. It can be assumed that the observed EcN specific
chemokine expression is induced via a NF-κB independ-
ent pathway. The JNK/AP-1 signaling cascade is a likely
candidate, since transcription and secretion of MCP-1 can
also be activated through this pathway triggered by TLR4
signaling [41]. It is a well-known fact that toll-like recep-
tor 4 (TLR4) and 5 (TLR5) recognize LPS [42] and bacte-
rial flagellin [43,44], respectively. Both receptors induce
among others the transcription of MCP-1, MIP-2α and
MIP-2β [45]. Induction of DSS colitis in TLR4-/- mice led
to an altered neutrophil recruitment due to diminished
MIP-2 expression by lamina propria macrophages. Thus,
TLR4 participates in the intestinal immune response to
luminal bacteria and the development of colitis [46].
Since both, EcN and E. coli MG1655 possess flagellin and
LPS, it can be speculated that an additional component of
EcN not yet identified is able to induce MCP-1 gene
expression. However, the semirough O6 lipopolysaccha-
ride phenotype of EcN, which is different from O6 LPS of
uropathogenic E. coli and which is responsible for serum
sensitivity of EcN [19], might also play a role in this con-
text.
Even though the proinflammatory activity of EcN, mani-
fested by MCP-1 gene expression and protein secretion,
appears surprising at first sight, the genome content of this
probiotic strain offers explanations for its proinflamma-
tory properties. Genome comparisons of probiotic EcN
and the uropathogenic E. coli (UPEC) strain CFT073 as
recently published by our laboratory [47] and Grozdanov
et al. [17] revealed a high degree of homology between
these two strains. The existence of about 130 "common
virulence factors" in probiotic EcN, as defined by the
PRINTS protein fingerprint database, suggests that these
proteins cannot be considered as virulence factors per se,
but may also contribute to the general fitness of EcN [47].
Conclusion
The results of our study revealed that EcN specifically
upregulated genes in confluent human intestinal epithe-
lial cell culture. The majorities of these genes were proin-
flammatory cytokines or belonged to inflammatory
pathways. These surrogate in vitro markers of probiotic
activity of EcN need to be corroborated in other model
systems to test their in vivo relevance. Additionally, the cell
culture model described here will serve as a readout, to
evaluate the impact of potential probiotic genes and gene
products of EcN, which will consecutively be identified,
when our genome sequencing project is finished.
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